Related Experiment Video
Updated: Jan 27, 2026
06:48
Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil
Published on: July 29, 2020
5.1K
Expedited pharma patenting in Brazil
1Partner at IP firm Dannemann Siemsen, Partner at the Patent Department, Rio de Janeiro, Brazil.
Pharmaceutical Patent Analyst
|March 20, 2019
Summary
Expedited examination of pharmaceutical patent applications in Brazil significantly reduces lengthy backlogs. This fast-track process, utilizing official regulations, shortens patent grant decisions from over a decade to just 0.5-3.5 years.
Area of Science:
- Intellectual Property Law
- Pharmaceutical Science
- Brazilian Regulatory Affairs
Background:
- Significant examination backlogs in Brazilian patent applications have historically caused long delays.
- Pharmaceutical patent applications in Brazil faced a mean examination time of 11-13 years as of 2017.
Purpose of the Study:
- To provide an updated overview of expedited examination processes for pharmaceutical patent applications in Brazil.
- To highlight effective alternatives for overcoming patent application examination delays.
Main Methods:
- Analysis of official regulations for expedited patent examination in Brazil.
- Review of case examples of pharmaceutical patents processed under accelerated examination rules.
Main Results:
- Official regulations for expediting patent examination have proven effective in reducing delays.
- Pharmaceutical patents utilizing fast-track rules received grant decisions within 0.5-3.5 years from the acceleration request.
Conclusions:
- Expedited examination pathways offer a viable solution to the protracted backlog of pharmaceutical patent applications in Brazil.
- The implementation of fast-track rules significantly enhances the efficiency of patent protection for pharmaceutical innovations.
